HOME >> MEDICINE >> NEWS
Drug-eluting and absorbable stents push interventional frontiers

ATLANTA, GA (March 13, 2006) -- Medicated stents that prevent arterial renarrowing are offering hope to patients with certain types of cardiovascular disease, while a novel stent that slowly dissolves into the artery wall is proving to be a safe alternative to conventional devices, according to research presented today at the American College of Cardiology's inaugural Innovation in Intervention: i2 Summit 2006 in Atlanta, Ga. A separate study tests the best approach to prevent blood clots in patients with acute coronary syndromes. Innovation in Intervention: i2 Summit is an annual meeting for practicing cardiovascular interventionalists sponsored by the American College of Cardiology in partnership with the Society for Cardiovascular Angiography and Interventions.

Prospective, Randomized Comparison of Routine Upfront Initiation versus Selective Use of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndromes: The ACUITY Timing Trial

In patients with acute coronary syndromes, doctors are unclear about whether it is better to give glycoprotein IIb/IIIa inhibitors (GPI, which prevents platelets from clumping together to form a blood clot) to all patients in the emergency room, or wait for the results of angiography and give GPI only if angioplasty is needed to restore blood flow to the heart. The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Timing trial will answer that question.

Acute coronary syndrome (ACS) is an umbrella diagnosis that encompasses both unstable angina and a type of heart attack known as non-ST elevation myocardial infarction (NSTEMI). Today, drug therapy typically consists of aspirin, clopidogrel, heparin, and a glycoprotein IIb/IIIa inhibitor (GPI), each of which interferes with a specific step in blood clotting. Patients also typically have an angiography within a few days to determine whether further, invasive treatment with angioplasty or surgery is needed. '"/>


13-Mar-2006


Page: 1 2 3 4 5

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. New biodegradable magnesium stents for coronary arteries
7. Bare-metal stents are better for some heart patients
8. Off-label and untested use of drug-coated stents appears widespread
9. Studies highlight real world use, safety of drug-eluting stents
10. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes
11. SCAI issues clinical alert on drug-eluting stents and late thrombosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, ... million people across hundreds of U.S. cities to raise awareness of suicide prevention. ...
(Date:9/3/2020)... ... September 03, 2020 , ... ... Sunrise Technologies WALI wireless parking lot controller. This advanced LED wireless dimming controller, ... light trespass, and protecting the night sky against light pollution. Leo Smith, the ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the ... with Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for ... code (R code) in the next edition of the U.S. International Classification of ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... of Blood Cancer Awareness Month (BCAM) and its international Light it Red ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis Chiropractic Software and ... the launch of its integrated, HIPAA compliant, telehealth solution, available to US-based clients ... under 90 seconds. , According to the U.S. Department of Health & ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... WILMINGTON, Mass. (PRWEB) , ... September 02, 2020 ... ... in handheld 1064nm Raman technology, will moderate a roundtable discussion among industry professionals ... The roundtable will be hosted by American Pharmaceutical Review and will ...
(Date:9/2/2020)... , ... September 02, 2020 , ... U.S. Dermatology ... Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. , ... B.A. from the University of California, Berkley. He went on to receive his M.D. ...
(Date:9/1/2020)... N.Y. (PRWEB) , ... September 01, 2020 , ... ... dermatologist, and Director of Cosmetics and Laser Surgery at the University of Rochester ... Dermatologic Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from the ...
Breaking Medicine Technology:
Cached News: